The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) for treatment-refractory hormone-receptor positive (HR+)/HER2- metastatic breast cancer (mBC).
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Novartis; Pfizer; Spectrum Pharmaceuticals
 
Jennifer Robinson Diamond
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Casi Pharmaceuticals (Inst); Genentech/Roche (Inst); MedImmune (Inst); Millennium (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst); Scripps Hospital (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Takeda; Takeda
 
Linda T. Vahdat
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - Eisai
Research Funding - Abbvie (Inst); AstraZeneca (Inst); celldex (Inst); Clovis Oncology (Inst); Galena Biopharma (Inst); Immunomedics (Inst); millennium (Inst); Optimer Biotechnology (Inst); PharmaMar (Inst); Polyphor (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; Genentech; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Bristol-Myers Squibb; Eisai; Eisai; Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Lilly; Nektar; Novartis; Pfizer
 
Rebecca L. Moroose
Stock and Other Ownership Interests - Amgen; Johnson & Johnson
Honoraria - Genentech; Pfizer
Consulting or Advisory Role - Lilly
Speakers' Bureau - Genentech; Lilly; Pfizer
Research Funding - Immunomedics (Inst)
 
Ingrid A. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
Research Funding - Novartis; Pfizer
 
Vandana Gupta Abramson
Consulting or Advisory Role - Novartis
Research Funding - Astellas Pharma; Genentech/Roche
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Novartis
 
Robert M. Sharkey
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Consulting or Advisory Role - Immunomedics
Travel, Accommodations, Expenses - Immunomedics
 
Sarah A. Washkowitz
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Consulting or Advisory Role - Immunomedics
Travel, Accommodations, Expenses - Immunomedics
Other Relationship - venBio (I)
 
William A. Wegener
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
David M. Goldenberg
Employment - Immunomedics; Immunomedics (I)
Leadership - Immunomedics; Immunomedics (I)
Stock and Other Ownership Interests - Immunomedics; Immunomedics (I)
Patents, Royalties, Other Intellectual Property - Patent protection for multiple antibody-based products and procedures
Travel, Accommodations, Expenses - Immunomedics (I); Immunomedics (I)
 
Kevin Kalinsky
Stock and Other Ownership Interests - Novartis (I)
Consulting or Advisory Role - Amgen; bioTheranostics; Eisai; Lilly; Novartis; pfizer